Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH).
- Disclosed ownership: 6.2%.
- Date of event: 23 Mar 2026.
INTEGRATED CORE STRATEGIES (US) LLC - 23 Mar 2026 SCHEDULE 13G Report for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Integrated Core Strategies (US) LLC
- Symbol
- RVPH
- Shares outstanding
- 12,805,677 shares
- Disclosed Ownership
- 793,952 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G
- Filing time
- 30 Mar 2026, 17:34:04 UTC
- Date of event
- 23 Mar 2026
- Previous filing
- 16 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 6.2% ownership in Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH) on 23 Mar 2026."
What Changed
- Previous schedule filing date: 16 Jan 2026.
- Current filing was accepted on 30 Mar 2026, 17:34.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 6.2% | 793,952 | 0 | 793,952 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 6.2% | 793,952 | 0 | 793,952 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 6.2% | 793,952 | 0 | 793,952 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 6.2% | 793,952 | 0 | 793,952 | /s/ Israel A. Englander | Israel A. Englander |